Eli Lilly vs UnitedHealth Group

Eli Lilly (LLY), health care, and UnitedHealth Group (UNH), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Eli Lilly is worth $1.26T on the stock market and UnitedHealth Group $356.7B: Eli Lilly is valued at 3.5 times as much. Eli Lilly trades at 46.0 times earnings and UnitedHealth Group at 22.7. Over the past year Eli Lilly's share price has moved +39.0% and UnitedHealth Group's +31.4%.

Key facts

Eli Lilly market value
$1.26T
UnitedHealth Group market value
$356.7B
Eli Lilly P/E
46.0
UnitedHealth Group P/E
22.7
Eli Lilly revenue
$65.2BFY to 2025-12-31
UnitedHealth Group revenue
$447.6BFY to 2025-12-31
Superinvestors holding both
11

Market values as of .

Eli Lilly vs UnitedHealth Group: every measure side by side
Measure Eli Lilly UnitedHealth Group
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$1.26Thigher$356.7Blower
Revenue$65.2Blower$447.6Bhigher
Earnings$20.6Bhigher$12.1Blower
Employees50,000lower390,000higher
Total assets$112.5Blower$309.6Bhigher
Valuation
P/E46.0higher22.7lower
P/S19.4higher0.8lower
P/B31.3higher3.6lower
Dividend yield0.47%lower2.20%higher
Profitability
Operating margin—4.24%
Balance sheet
Net assets$26.5Blower$100.1Bhigher
Total liabilities$85.9Blower$207.9Bhigher
Total debt$42.5Blower$77.7Bhigher
Cash on hand$7.3Blower$24.4Bhigher
Price change
Today-1.06%higher-3.39%lower
1 year+39.0%higher+31.4%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio (under "Both": Eli Lilly / UnitedHealth Group). Who owns LLY · Who owns UNH

Further comparisons

Learn

Questions and answers

Which is bigger, Eli Lilly or UnitedHealth Group?

By market value, Eli Lilly is the larger: $1.26T against $356.7B for UnitedHealth Group. By revenue in its latest fiscal year, UnitedHealth Group is the larger: $447.6B against $65.2B for Eli Lilly.

Which has the higher P/E ratio?

Eli Lilly: 46.0, against 22.7 for UnitedHealth Group. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher dividend yield?

UnitedHealth Group: 2.20%, against 0.47% for Eli Lilly. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which has more debt?

UnitedHealth Group: $77.7B, against $42.5B for Eli Lilly. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Eli Lilly and UnitedHealth Group?

In their latest 13F filings, Jensen team, Mairs & Power team, Jeremy Grantham (co-founder), Ken Fisher, Rajiv Jain, Ken Griffin, Temasek, Cliff Asness, Paul Tudor Jones, Israel Englander and Dodge & Cox team hold both.

Cite this page

Funkfolio, “Eli Lilly vs UnitedHealth Group”, data as of 17 November 2026. https://funkfolio.com/compare/lly-vs-unh

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.